Literature DB >> 15140974

Complementation of a binding-defective retrovirus by a host cell receptor mutant.

Zhaohui Qian1, Hongzhe Wang, Cyril Empig, W French Anderson, Lorraine M Albritton.   

Abstract

The entry of ecotropic murine leukemia virus (MLV) into cells requires the interaction of the envelope protein (Env) with its receptor, mouse cationic amino acid transporter 1 (mATRC1). An aspartic acid-to-lysine change at position 84 (D84K) of ecotropic Moloney MLV Env abolishes virus binding and infection. We recently identified lysine 234 (rK234) in mATRC1 as a residue that influences virus binding and infection. Here we show that D84K virus infection increased 3,000-fold on cells expressing receptor with an rK234A change and 100,000-fold on cells expressing an rK234D change. The stronger complementation of D84K virus infection by rK234D than by the rK234A receptor suggests that although the major reason for loss of infection of D84K and D84R virus is due to steric hindrance and charge repulsion, the loss of an interaction of D84 with receptor appears to contribute as well. Taken together, these results indicate that D84 is very close to rK234 of mATRC1 in the bound complex and there is likely an interaction between them. The definitive localization of the receptor binding site on SU should facilitate the design of chimeric envelope proteins that target infection to new receptors by replacing the receptor binding site with an exogenous ligand sequence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140974      PMCID: PMC415786          DOI: 10.1128/JVI.78.11.5766-5772.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.

Authors:  M Chung; K Kizhatil; L M Albritton; G N Gaulton
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  System y+ localizes to different membrane subdomains in the basolateral plasma membrane of epithelial cells.

Authors:  Krishnakumar Kizhatil; Lorraine M Albritton
Journal:  Am J Physiol Cell Physiol       Date:  2002-08-22       Impact factor: 4.249

3.  Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter.

Authors:  H Wang; M P Kavanaugh; R A North; D Kabat
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.

Authors:  T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

Authors:  L M Albritton; L Tseng; D Scadden; J M Cunningham
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

6.  Identification of a critical basic residue on the ecotropic murine leukemia virus receptor.

Authors:  Zhaohui Qian; Robin Donald; Hongzhe Wang; Qianmin Chen; Lorraine M Albritton
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Transport of cationic amino acids by the mouse ecotropic retrovirus receptor.

Authors:  J W Kim; E I Closs; L M Albritton; J M Cunningham
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

8.  Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus.

Authors:  T Yoshimoto; E Yoshimoto; D Meruelo
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.

Authors:  M J Kadan; S Sturm; W F Anderson; M A Eglitis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  6 in total

1.  Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.

Authors:  Fang Li; Byoung Y Ryu; Robin L Krueger; Scott A Heldt; Lorraine M Albritton
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.

Authors:  Guiqing Peng; Dawei Sun; Kanagalaghatta R Rajashankar; Zhaohui Qian; Kathryn V Holmes; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

3.  Identification of H209 as Essential for pH 8-Triggered Receptor-Independent Syncytium Formation by S Protein of Mouse Hepatitis Virus A59.

Authors:  Pei Li; Yiwei Shan; Wangliang Zheng; Xiuyuan Ou; Dan Mi; Zhixia Mu; Kathryn V Holmes; Zhaohui Qian
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

4.  Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins.

Authors:  Xiuyuan Ou; Wangliang Zheng; Yiwei Shan; Zhixia Mu; Samuel R Dominguez; Kathryn V Holmes; Zhaohui Qian
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation.

Authors:  Zhaohui Qian; Samuel R Dominguez; Kathryn V Holmes
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

6.  Glycine 29 Is Critical for Conformational Changes of the Spike Glycoprotein of Mouse Hepatitis Virus A59 Triggered by either Receptor Binding or High pH.

Authors:  Dan Mi; Xiuyuan Ou; Pei Li; Guiqing Peng; Yan Liu; Ruixuan Guo; Zhixia Mu; Fang Li; Kathryn Holmes; Zhaohui Qian
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.